This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alnylam Pharmaceuticals Inc (ALNY)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash and Equivalents 180.90M 75.18M 53.17M 51.41M
Receivables 8.30M 39.94M 4.25M 104.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 1.11B 746.37M 254.03M 125.46M
Property, Plant & Equipment, Gross 79.31M 67.83M 57.76M 55.27M
Accumulated Depreciation & Depletion 51.49M 46.09M 41.32M 35.47M
Property, Plant & Equipment, Net 27.81M 21.74M 16.45M 19.80M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 253.31M 279.82M 150.05M 142.26M
Total Non-Current Assets 281.12M 333.23M 166.50M 162.06M
Liabilities & Shareholder Equity
Total Assets 1.39B 1.08B 420.53M 287.52M
Accounts Payable 16.79M 15.11M 5.90M 4.42M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.16M 1.00M 1.11M 0.00
Total Current Liabilities 62.10M 95.33M 53.86M 48.34M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 5.43M 5.01M 2.92M 0.00
Other Non-Current Liabilities 54.27M 42.98M 93.39M 105.12M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 59.70M 47.99M 96.32M 105.12M
Total Liabilities 121.80M 143.33M 150.18M 153.47M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.26B 936.27M 270.35M 134.05M
Common Par 851.00K 772.00K 637.00K 525.00K
Additional Paid In Capital 2.51B 1.84B 846.23M 624.88M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.25B -956.63M -596.24M -507.01M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 4.37M 48.76M 19.72M 15.66M
Total Capitalization 1.26B 936.27M 270.35M 134.05M
Total Equity 1.26B 936.27M 270.35M 134.05M
Total Liabilities & Stock Equity 1.39B 1.08B 420.53M 287.52M
Total Common Shares Outstanding 85.09M 77.20M 63.74M 52.49M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 83.99M 74.28M 61.55M 50.29M
Diluted Weighted Shares Outstanding 83.99M 74.28M 61.55M 50.29M
Number of Employees 369 256 165 129
Number of Part-Time Employees 0 0 0 0

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ALNY Alnylam Pharmaceuticals Inc

Chart of ALNY

Analysts Ratings for ALNY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 7 6 6
Moderate Buy 0 0 0 0
Hold 1 1 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ALNY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs